Deals8 Jul 2025, 02:01 am
Nectar Lifesciences Ltd. to Sell Active Pharmaceutical Ingredients and Formulations Business for INR 12,70,00,00,000
AI Summary
Nectar Lifesciences Ltd. has approved the sale of its active pharmaceutical ingredients and formulations business to Ceph Lifesciences Private Limited for INR 12,70,00,00,000. The sale is expected to be completed by September 20, 2025, subject to adjustments as per the Business Transfer Agreement (BTA). The business being sold contributed 65.39% of the net worth and 98.33% of the total revenue of the company in the financial year 2024-25. The company will seek the approval of its shareholders for this transaction in the forthcoming EGM.
Key Highlights
- Nectar Lifesciences Ltd. to sell its active pharmaceutical ingredients and formulations business for INR 12,70,00,00,000.
- The business being sold contributed 65.39% of the net worth and 98.33% of the total revenue of the company in the financial year 2024-25.
- The sale is expected to be completed by September 20, 2025, subject to adjustments as per the BTA.
- The company will seek the approval of its shareholders for this transaction in the forthcoming EGM.